Reduced leaflet motion in bioprosthetic aortic valves-the FDA perspective

New England Journal of Medicine

Volumn 373, Issue 21, 2015, Pages 1996-1998

  Laschinger, John C ^a   Wu, Changfu ^a   Ibrahim, Nicole G ^a   Shuren, Jeffrey E ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEART HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSTHORACIC ECHOCARDIOGRAPHY; ADVERSE EFFECTS; AORTA VALVE; BIOPROSTHESIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; MALE; PATHOPHYSIOLOGY; THROMBOSIS;

ANTICOAGULANT AGENT;

ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; MALE; THROMBOSIS;

EID: 84947790221     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1512264     Document Type: Review

References (3)

1. Mylotte D, Andalib A, Thériault-Lauzier P, et al. Transcatheter heart valve failure: a systematic review. Eur Heart J 2015;36:1306-27.
2. Carroll JD, Shuren J, Jensen TS, et al. Transcatheter Valve Therapy Registry is a model for medical device innovation and surveillance. Health Aff (Millwood) 2015;34: 328-34.
3. Carroll JD, Edwards FH, Marinac-Dabic D, et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. J Am Coll Cardiol 2013;62:1026-34.